These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4229539)

  • 1. [Clinical and pathophysiologic aspects of the therapy of schizophrenic psychotics with nicotinic acid amide].
    Neumann H
    Nervenarzt; 1967 Nov; 38(11):511-4. PubMed ID: 4229539
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study.
    Ananth JV; Vacaflor L; Kekhwa G; Sterlin C; Ban TA
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):406-10. PubMed ID: 4261601
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of nicotinic acid on the frequency and duration of re-hospitalization of schizophrenic patients; a controlled comparison study.
    Hoffer A
    Int J Neuropsychiatry; 1966 Jun; 2(3):234-40. PubMed ID: 4225426
    [No Abstract]   [Full Text] [Related]  

  • 4. Nicotinic acid and nicotinamide adenine dinucleotide (NAD) therapy in schizophrenia: a review.
    Wittkopp TA; Abuzzahab FS
    Behav Neuropsychiatry; 1972; 4(7-8):6-12. PubMed ID: 4348727
    [No Abstract]   [Full Text] [Related]  

  • 5. A chemical treatment for schizophrenia.
    Alvarez WC
    Geriatrics; 1967 Mar; 22(3):111-2. PubMed ID: 4225316
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary note on the use of nicotinamide in the treatment of schizophrenia].
    Magalhães MB
    Resen Clin Cient; 1969; 38(11):295-6. PubMed ID: 4254730
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of nicotinic acid and/or nicotinamide in high doses to treat schizophrenia.
    Hoffer A
    Can J Psychiatr Nurs; 1966 Oct; 7(8):5-6. PubMed ID: 4224196
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemistry of nicotinic acid and nicotinamide.
    Hoffer A
    Psychosomatics; 1967; 8(2):95-100. PubMed ID: 4227744
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug therapy.
    Stone WN; Hofling CK; Winslow WW
    Prog Neurol Psychiatry; 1971; 26():529-51. PubMed ID: 4274994
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Dr. Pauling comments on the comments.
    Pauling L
    Am J Psychiatry; 1974 Dec; 131(12):1405-6. PubMed ID: 4279560
    [No Abstract]   [Full Text] [Related]  

  • 11. Niacin and the schizophrenic patient.
    Newbold HL; Mosher LR
    Am J Psychiatry; 1970 Oct; 127(4):535-6. PubMed ID: 4248216
    [No Abstract]   [Full Text] [Related]  

  • 12. [Some indices of nicotinic acid metabolism and the possibility of its use in the combined treatment of laryngeal cancer].
    Opanashchenko GA
    Zh Ushn Nos Gorl Bolezn; 1968; 28(3):15-20. PubMed ID: 4311596
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemical treatment possibilities in psychoses].
    Kanig K; Oesterle W
    Med Welt; 1969 Sep; 36():1938-45. PubMed ID: 4241466
    [No Abstract]   [Full Text] [Related]  

  • 14. Niacinamide. Monograph.
    Altern Med Rev; 2002 Dec; 7(6):525-9. PubMed ID: 12495377
    [No Abstract]   [Full Text] [Related]  

  • 15. Nicotinic acid as an adjuvant in the treatment of chronic schizophrenic patients with special reference to changes in higher nervous activity.
    Saarma J; Vasar H
    Curr Ther Res Clin Exp; 1970 Nov; 12(11):729-33. PubMed ID: 4993126
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: NAD and chronic schizophrenia.
    Altus MS
    Am J Psychiatry; 1974 Sep; 131(9):1043-4. PubMed ID: 4370155
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictive factors of the number and the dose of anti-psychotics in a cohort of schizophrenic patients.
    Lukasiewicz M; Gasquet I; Casadebaig F; Philippe A; Ledoux S; Reynaud M; Falissard B
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):594-601. PubMed ID: 16329157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new hepatoprotective preparation. Biochemical aspects and clinical studies].
    Boselli A
    Clin Ter; 1968 Jan; 44(2):115-56. PubMed ID: 4244601
    [No Abstract]   [Full Text] [Related]  

  • 19. Carphenazine in the intensive care of chronically ill psychotics.
    Hanenson I
    Int J Neuropsychiatry; 1967 Aug; 3(4):332-6. PubMed ID: 4863506
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical study of a new drug association with a base of nucleosides in therapy of some liver diseases].
    De Martiis M
    Clin Ter; 1966 Aug; 38(4):331-41. PubMed ID: 4229942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.